Skip to main content

Table 1 Disease characteristics of SLE patients

From: Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness

  SLE (n= 30)
ACR criteria, n (%)  
   Malar rash 13 (43%)
   Discoid rash 6 (20%)
   Photosensitivity 12 (40%)
   Oral ulcers 9 (30%)
   Arthritis 20 (66%)
   Serositis 16 (53%)
   Renal disorder 13 (43%)
   Neurological disorder 1 (3%)
   Hematological disorder 23 (77%)
   Immunological disorder 26 (87%)
   Antinuclear antibody 30 (100%)
Duration of disease, months 146 (49 to 209)
SLEDAI 4 (2 to 4)
Anti-dsDNA, Farr 20 (6 to 140)
Complement C3, g/l 0.89 (0.74 to 1.06)
Complement C4, g/l 0.12 (0.09 to 0.17)
C-reactive protein, mg/l 1.8 (0.5 to 4.5)
Creatinine Clearance, ml/min 106 (93 to 131)
Prednisolone use, n (%) 19 (63%)
   Dose, mg/day 7.5 (5 to 10)
Hydroxychloroquine use, n (%) 15 (50%)
   Dose, mg/dag 400 (400 to 400)
Azathioprine use, n (%) 11 (37%)
   Dose, mg/day 100 (50 to 150)
  1. Unless stated otherwise, data are expressed as median (25 to 75%). ACR, American College of Rheumatology; SLEDAI, SLE disease activity index; anti-dsDNA, anti-double stranded DNA.